GE HealthCare acquires AI ultrasound company

GE HealthCare has picked up Caption Health, an AI ultrasound company targeting early disease detection.

Financial terms of the deal were not disclosed in the announcement from GE HealthCare, though the company plans to use cash on hand to finance it. Caption Health, based in California, has raised more than $62 million through seven funding rounds, according to Crunchbase. The deal will fold Caption Health into GE HealthCare’s $3 billion ultrasound business, supporting the portfolio with AI-enabled imaging. GE HealthCare officially became a standalone entity in early January after GE split into three separate businesses––GE HealthCare, GE Vernova and GE Aerospace.

Caption Health uses AI to assist in its ultrasound examinations and detect disease such as heart failure at doctors’ offices, at home or alternate sites of care. According to GE HealthCare, heart ultrasounds are the primary examination to determine heart failure, which is the most common diagnosis in the U.S. for hospitalized patients older than 65. With heart disease and No. 1 cause of death in the United States, earlier detection could lead to earlier interventions.

“Guiding ultrasound users during examinations with the help of AI is of growing importance, especially as we reach a broader set of healthcare professionals,” GE HealthCare Ultrasound President and CEO Roland Rott said in a statement. “Caption Health’s AI applications help enable reliable, consistent ultrasound examinations to deliver more precise diagnoses, improved treatment decision-making, and ultimately improved patient outcomes. This tuck-in acquisition will help expand affordable access to ultrasound imaging to novice users and is aligned with a broader shift to precision care globally.”

Caption Health will continue to provide management and administrative services to affiliated medical services providers, referred to as Caption Care, as part of the acquisition. The Caption Health AI technology could be used by trained technicians to perform cardiac ultrasounds in alternate sites of care and potentially within patients’ homes in the future. 

Caption Health also has a pipeline of AI software, including for the use of ultrasound in pulmonary applications.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.